Article info

Download PDFPDF
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease

Authors

  1. Correspondence to Professor Yoshimasa Aso, Department of Endocrinology and Metabolism, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan; yaso{at}dokkyomed.ac.jp
View Full Text

Citation

Aso Y, Sagara M, Niitani T, et al
Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease

Publication history

  • Accepted May 4, 2021
  • First published May 20, 2021.
Online issue publication 
September 27, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.